Methylprednisolone 32 MG Oral Tablet [Medrol] — RxCUI 207141
RxNorm drug concept · Semantic branded drug
RxCUI 207141
Semantic branded drug · SBD
Retired or remapped concept 4 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI207141
Official nameMethylprednisolone 32 MG Oral Tablet [Medrol]
Concept typeSemantic branded drug (SBD)
RxNorm statusRetired or remapped concept
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)151 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Methylprednisolone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Methylprednisolone is used for a very wide range of conditions — basically anything where your immune system or inflammation is causing the problem. That includes severe allergic r...
- What conditions does methylprednisolone actually treat?
- It really depends on what you're being treated for. Some people take a short course for an acute flare and then stop. Others need longer-term treatment for chronic conditions. The...
- How long will I need to take this medication?
🕸️ Concept Web
No related-concept groups were available for this RxCUI in the loaded RxNorm data. That does not prove that no related concepts exist.
📦 FDA Products & Package NDCs
4 products · 5 package NDCs
5 package NDCs map to RxCUI 207141 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00009-0020-01 | 100 TABLET in 1 BOTTLE (0009-0020-01) | Medrol | Pharmacia & Upjohn Company LLC | 2013-09-20 |
| 00009-0022-01 | 25 TABLET in 1 BOTTLE (0009-0022-01) | Medrol | Pharmacia & Upjohn Company LLC | 1957-10-24 |
| 00009-0056-02 | 100 TABLET in 1 BOTTLE (0009-0056-02) | Medrol | Pharmacia & Upjohn Company LLC | 1957-10-24 |
| 00009-0056-04 | 1 DOSE PACK in 1 CARTON (0009-0056-04) / 21 TABLET in 1 DOS... | Medrol | Pharmacia & Upjohn Company LLC | 1957-10-24 |
| 00009-0073-01 | 50 TABLET in 1 BOTTLE (0009-0073-01) | Medrol | Pharmacia & Upjohn Company LLC | 1957-10-24 |
Observed labelers:
Pharmacia & Upjohn Company LLC (5)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7509 | Methylprednisolone oral | 5 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.